Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/26250
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNishimura, Akira-
dc.contributor.authorNaruto, Takuya-
dc.contributor.authorMiyamoto, Satoshi-
dc.contributor.authorGrigg, Andrew P-
dc.contributor.authorBosco, Julian J-
dc.contributor.authorHoshino, Akihiro-
dc.contributor.authorAmano, Keishiro-
dc.contributor.authorIwamoto, Shotaro-
dc.contributor.authorHirayama, Masahiro-
dc.contributor.authorMigita, Masahiro-
dc.contributor.authorOhara, Osamu-
dc.contributor.authorTakagi, Masatoshi-
dc.contributor.authorMorio, Tomohiro-
dc.contributor.authorvan Zelm, Menno C-
dc.contributor.authorKanegane, Hirokazu-
dc.date2021-04-14-
dc.date.accessioned2021-04-19T05:58:48Z-
dc.date.available2021-04-19T05:58:48Z-
dc.date.issued2021-06-
dc.identifier.citationBritish Journal of Haematology 2021; 193(6): 1277-1281en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/26250-
dc.language.isoeng
dc.subjectBruton’s tyrosine kinaseen
dc.subjectX-linked agammaglobulinemiaen
dc.subjectacute lymphoblastic leukemiaen
dc.subjectacute megakaryoblastic leukemiaen
dc.subjecttumor suppressoren
dc.titleGenomics analysis of leukaemia predisposition in X-linked agammaglobulinaemia.en
dc.typeJournal Articleen
dc.identifier.journaltitleBritish Journal of Haematologyen
dc.identifier.affiliationDepartment of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japanen
dc.identifier.affiliationLaboratory for Integrative Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japanen
dc.identifier.affiliationDepartment of Lifetime Clinical Immunology, Tokyo Medical and Dental University (TMDU), Tokyo, Japanen
dc.identifier.affiliationDepartment of Allergy, Immunology and Respiratory Medicine, The Alfred Hospital, Melbourne, Australiaen
dc.identifier.affiliationDepartment of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Australiaen
dc.identifier.affiliationThe Jeffrey Modell Diagnostic and Research Centre for Primary Immunodeficiencies, Melbourne, VIC, Australiaen
dc.identifier.affiliationClinical Haematologyen
dc.identifier.affiliationDepartment of Applied Genomics, Kazusa DNA Research Institute, Kisarazu, Japanen
dc.identifier.affiliationDepartment of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japanen
dc.identifier.affiliationDepartment of Pediatrics, Mie University, Mie, Japanen
dc.identifier.affiliationDepartment of Pediatrics, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japanen
dc.identifier.affiliationDepartment of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japanen
dc.identifier.affiliationDepartment of Child Health and Development, Tokyo Medical and Dental University (TMDU), Tokyo, Japanen
dc.identifier.affiliationOlivia Newton-John Cancer Research Instituteen
dc.identifier.doi10.1111/bjh.17459en
dc.type.contentTexten
dc.identifier.orcid0000-0002-9127-807Xen
dc.identifier.orcid0000-0002-7580-9184en
dc.identifier.orcid0000-0002-8696-9378en
dc.identifier.pubmedid33855700
local.name.researcherGrigg, Andrew P
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.languageiso639-1en-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptClinical Haematology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

28
checked on Sep 30, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.